Cargando…
Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
Kidney disease associated with diabetes mellitus is a major health problem worldwide. Although established therapeutic strategies, such as appropriate blood glucose control, blood pressure control with renin–angiotensin system blockade, and lipid lowering with statins, are used to treat diabetes, th...
Autores principales: | Kanasaki, Keizo, Taduri, Gangadhar, Koya, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565176/ https://www.ncbi.nlm.nih.gov/pubmed/23390421 http://dx.doi.org/10.3389/fendo.2013.00007 |
Ejemplares similares
-
MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
por: Srivastava, Swayam Prakash, et al.
Publicado: (2013) -
Combating Kidney Fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2014) -
Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
por: Shi, Sen, et al.
Publicado: (2016) -
Lipid mediators in diabetic nephropathy
por: Srivastava, Swayam Prakash, et al.
Publicado: (2014) -
Sirtuins and renal diseases: relationship with aging and diabetic nephropathy
por: Kitada, Munehiro, et al.
Publicado: (2012)